Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial

NCT05135546 is registered in ClinicalTrials.gov with Supergene, LLC as lead sponsor.

NCT NCT05135546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial
Lead sponsor
Supergene, LLC
Phase
Phase 2/3
Overall status
Terminated
Start date
December 27, 2021
Completion date
May 31, 2023
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19